AB008. S2-2. Surgical approach to intrahepatic cholangiocarcinoma
Speaker Abstracts

AB008. S2-2. Surgical approach to intrahepatic cholangiocarcinoma

Shishir K. Maithel

Emory Liver and Pancreas Center, Winship Cancer Institute, Division of Surgical Oncology, Department of Surgery, Emory University, Atlanta, USA

Correspondence to: Shishir K. Maithel. Emory Liver and Pancreas Center, Winship Cancer Institute, Division of Surgical Oncology, Department of Surgery, Emory University, Atlanta, USA. Email: smaithe@emory.edu.

Abstract: The talk will cover the staging of intrahepatic cholangiocarcinoma and how it pertains to the ideal surgical management. We will also cover other alternative therapies to resection, such as liver-directed therapies. Next, we will combine the information to define technically and oncologically resectable tumors, unresectable tumors, and borderline resectable tumors to suggest clinical pathways for management of this disease. Finally, we will discuss a prospective trial currently underway utilizing preoperative chemotherapy prior to resection for oncologically high-risk tumors.

Keywords: Intrahepatic cholangiocarcinoma; clinical pathways; technical resectability; oncologic resectability; clinical trials

Cite this abstract as: Maithel SK. Surgical approach to intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr 2019;8(Suppl 1):AB008. doi: 10.21037/hbsn.2019.AB008

Article Options

Download Citation

Share